Outsourced Pharma: ADC Capacity Update

We are a leading CRO and CDMO that specializes in the development and manufacture of complex biologics, bioconjugates, and antibody-drug conjugates (ADCs).

Recently Petra Dieterich Ph.D, Senior Vice President at Abzena spoke to Outsourced Pharma about our ADC services and solutions, as well as capacity updates.

Read the article in full here

About Abzena

By seamlessly integrating early R&D with comprehensive cGMP manufacturing capabilities in biologics, chemistry, and conjugation, Abzena consistently delivers high-quality products and data packages that support our partners’ regulatory submissions and product requirements.